Addex Therapeutics Ltd (ADXN)

Addex Therapeutics Statistics

Total Valuation

ADXN has a market cap or net worth of $6.14 million. The enterprise value is $2.47 million.

Market Cap	6.14M
Enterprise Value	2.47M

Important Dates

The next confirmed earnings date is Monday, March 24, 2025, before market open.

Earnings Date	Mar 24, 2025
Ex-Dividend Date	n/a

Share Statistics

ADXN has 98.32 million shares outstanding. The number of shares has increased by 42.00% in one year.

Current Share Class	n/a
Shares Outstanding	98.32M
Shares Change (YoY)	+42.00%
Shares Change (QoQ)	-41.48%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	34.26M

Valuation Ratios

The trailing PE ratio is 0.96.

PE Ratio	0.96
Forward PE	n/a
PS Ratio	8.76
Forward PS	n/a
PB Ratio	0.47
P/TBV Ratio	0.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.39
EV / Sales	3.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.59, with a Debt / Equity ratio of 0.00.

Current Ratio	4.59
Quick Ratio	4.36
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-506.87

Financial Efficiency

Return on equity (ROE) is -168.91% and return on invested capital (ROIC) is -90.07%.

Return on Equity (ROE)	-168.91%
Return on Assets (ROA)	-75.64%
Return on Invested Capital (ROIC)	-90.07%
Return on Capital Employed (ROCE)	-98.20%
Revenue Per Employee	$30,490
Profits Per Employee	$278,186
Employee Count	23
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.59% in the last 52 weeks. The beta is 1.94, so ADXN's price volatility has been higher than the market average.

Beta (5Y)	1.94
52-Week Price Change	-21.59%
50-Day Moving Average	7.72
200-Day Moving Average	8.70
Relative Strength Index (RSI)	48.90
Average Volume (20 Days)	11,639

Short Selling Information

Short Interest	1,471
Short Previous Month	3,339
Short % of Shares Out	0.18%
Short % of Float	n/a
Short Ratio (days to cover)	0.05

Income Statement

In the last 12 months, ADXN had revenue of $701,260 and earned $6.40 million in profits. Earnings per share was $0.06.

Revenue	701,260
Gross Profit	-7.21M
Operating Income	-13.11M
Pretax Income	-12.96M
Net Income	6.40M
EBITDA	-12.89M
EBIT	-13.11M
Earnings Per Share (EPS)	$0.06

Balance Sheet

The company has $3.96 million in cash and $51,813 in debt, giving a net cash position of $3.91 million or $0.04 per share.

Cash & Cash Equivalents	3.96M
Total Debt	51,813
Net Cash	3.91M
Net Cash Per Share	$0.04
Equity (Book Value)	13.10M
Book Value Per Share	0.13
Working Capital	3.77M

Cash Flow

In the last 12 months, operating cash flow was -$7.07 million and capital expenditures -$2,934, giving a free cash flow of -$6.66 million.

Operating Cash Flow	-7.07M
Capital Expenditures	-2,934
Free Cash Flow	-6.66M
FCF Per Share	-$0.07

Margins

Gross Margin	n/a
Operating Margin	-1,870.11%
Pretax Margin	-2,139.50%
Profit Margin	912.40%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ADXN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-42.00%
Shareholder Yield	-42.00%
Earnings Yield	104.14%
FCF Yield	-108.32%

Analyst Forecast

The average price target for ADXN is $30.00, which is 298.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.00
Price Target Difference	298.94%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on October 23, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Oct 23, 2023
Split Type	Reverse
Split Ratio	0.05:1

Scores

ADXN has an Altman Z-Score of -38.63 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-38.63
Piotroski F-Score	2